DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2296676/here-s-why-you-should-retain-starbucks-sbux-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296676 Jul 03, 2024 - Starbucks (SBUX) emphasizes the rollout of the equipment-driven siren system and store optimizations to drive growth. However, macroeconomic headwinds are a concern. 0

https://www.zacks.com/stock/news/2296512/nvidia-nvda-up-147-ytd-is-it-too-late-to-buy-the-stock-now?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2296512 Jul 03, 2024 - NVIDIA's (NVDA) strong product portfolio, leadership in AI and relentless innovation present a compelling investment opportunity. 0

https://www.zacks.com/stock/news/2296513/reasons-why-you-should-hold-roper-rop-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|zer_report_update-2296513 Jul 03, 2024 - Roper (ROP) gains from solid momentum in its businesses, acquired assets and shareholder-friendly moves. However, rising operating costs and high long-term debt remain concerns. 0

https://www.zacks.com/stock/news/2296508/4-reasons-to-add-essex-property-ess-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296508 Jul 03, 2024 - Essex Property (ESS) is likely to benefit from its strong property base on the West Coast, favorable demographics and a solid balance sheet. 0

https://www.zacks.com/stock/news/2296506/is-tesla-tsla-worth-a-bet-now-after-q2-delivery-beat?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2296506 Jul 03, 2024 - Tesla (TSLA) rallies 10% as Q2 deliveries beat expectations. From being the worst-performing S&P 500 stock in the Q1, TSLA surged 13% in Q2. Should you buy the stock now? 0

https://www.zacks.com/stock/news/2296489/reasons-to-retain-revvity-rvty-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296489 Jul 03, 2024 - Revvity's (RVTY) strong product portfolio raises optimism about the stock. 0

https://www.zacks.com/stock/news/2296487/here-s-why-you-should-retain-glaukos-gkos-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296487 Jul 03, 2024 - Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results. 0

https://seekingalpha.com/article/4702160-sunrun-four-reasons-im-neutral-for-now?source=feed_all_articles Jul 02, 2024 - Sunrun's negative free cash flow, high debt, and unfavorable interest rates may hinder its profitability and growth potential. Learn why RUN stock is a Hold. 0

https://www.fool.com/investing/2024/07/02/2-stocks-down-74-and-575-to-buy-right-now/?source=iedfolrf0000001 Jul 02, 2024 - Taking a buy-and-hold approach with these beaten-down stocks could reward investors with market-crushing returns. 0

https://www.zacks.com/stock/news/2296347/here-s-why-you-should-retain-ensign-group-ensg-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296347 Jul 02, 2024 - Ensign Group (ENSG) remains well-poised for growth on the back of solid segmental contributions, an expanding healthcare portfolio and sound cash reserves. 0